alvimopan (Compound)

Synonyms:Alvimopan, 156053-89-3, Alvimopan anhydrous, Adl 8-2698, anhydrous alvimopan, Alvimopan [INN], 2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid, LY 246736, LY246736, 145590-44-9, 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid, Q153V49P3Z, LY-246736, Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, ((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoyl)glycine, 2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid, N-[(2S)-2-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanoyl]glycine, UNII-Q153V49P3Z, trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, Glycine, N-((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, ALVIMOPAN [MI], ALVIMOPAN [MART.], ALVIMOPAN [WHO-DD], SCHEMBL49578, CHEMBL270190, GTPL7471, Alvimopan, >=98% (HPLC), HSDB 7704, DTXSID60166035, CHEBI:135686, HMS3886B09, ANHYDROUS ALVIMOPAN [MART.], BDBM50088381, MFCD09838268, s5935, AKOS015896476, CS-0536, DB06274, NCGC00378640-01, NCGC00378640-02, NCGC00378640-03, AS-35088, HY-13243, EN300-7393122, SR-01000945029, Q4738021, SR-01000945029-1, (((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYLPIPERIDIN-1-YL)METHYL)-3-PHENYLPROPANOYL)AMINO)ACETIC ACID, ((2(S)-((4(R)-(3-HYDROXYPHENYL)-3(R),4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)AMINO)ACETIC ACID, [[(S)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propionyl]amino]acetic acid, 2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)aceticacid, 2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid, GLYCINE, N-(2-((4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)-, (3R-((S*),3.ALPHA.,4.ALPHA.))-, N-((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)GLYCINE, NG0

Pubchem:PUBCHEM:5488548

Id:d4f757d5-585a-588b-9d1d-56cb952357f3

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View alvimopan's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for alvimopan.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with alvimopan.

Results found

Linked to

	Label	Description
	BRD-K07857022-002-01-1 Substance (Entity type)	A Substance
	DCSTRUCT ID 00143 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00143; PubChem_CID:5488548, FILE=drugcentral_drug_00143.json)
	alvimopan (be8b3ac6-698d-4c40-bccb-c9417712ec35) Collection (Entity type)	Metadatata for alvimopan
	alvimopan negatively regulates CEBPB Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alvimopan negatively regulates ANXA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alvimopan positively regulates TMEM255A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	alvimopan indication Postoperative ileus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	alvimopan negatively regulates H1-10 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alvimopan bioactivity Mu-type opioid receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	alvimopan positively regulates FBXW12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS